American Net Income from 2010 to 2026

ADLI Stock  USD 0.0001  0.00  0.000003%   
American Medical's Net Income is increasing with slightly volatile movements from year to year. Net Income is estimated to finish at about 183.7 K this year. For the period between 2010 and 2026, American Medical, Net Income quarterly trend regression had mean deviation of  16,518 and range of 140.4 K. View All Fundamentals
 
Net Income  
First Reported
2010-12-31
Previous Quarter
174.9 K
Current Value
183.7 K
Quarterly Volatility
34 K
 
Credit Downgrade
 
Yuan Drop
 
Covid
 
Interest Hikes
Check American Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among American Medical's main balance sheet or income statement drivers, such as Interest Expense of 0.0, Selling General Administrative of 1.8 M or Total Revenue of 2.1 M, as well as many indicators such as Price To Sales Ratio of 0.57, Dividend Yield of 0.0182 or Days Sales Outstanding of 52.59. American financial statements analysis is a perfect complement when working with American Medical Valuation or Volatility modules.
  
Build AI portfolio with American Stock
Check out the analysis of American Medical Correlation against competitors.
The Net Income trend for American Medical Technologies offers valuable insights into the company's financial trajectory and strategic direction. By examining multi-year patterns, investors can identify whether American Medical is strengthening or weakening its position, and how this metric correlates with broader market conditions and industry benchmarks.

Latest American Medical's Net Income Growth Pattern

Below is the plot of the Net Income of American Medical Technologies over the last few years. Net income is one of the most important fundamental items in finance. It plays a large role in American Medical Tec financial statement analysis. It represents the amount of money remaining after all of American Medical Technologies operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue. It is American Medical's Net Income historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in American Medical's overall financial position and show how it may be relating to other accounts over time.
ViewLast Reported 194.36 K10 Years Trend
Slightly volatile
   Net Income   
       Timeline  

American Net Income Regression Statistics

Arithmetic Mean184,335
Geometric Mean178,550
Coefficient Of Variation18.44
Mean Deviation16,518
Median194,364
Standard Deviation33,989
Sample Variance1.2B
Range140.4K
R-Value0.33
Mean Square Error1.1B
R-Squared0.11
Significance0.20
Slope2,209
Total Sum of Squares18.5B

American Net Income History

2026183.7 K
2025174.9 K
2011194.4 K
201054 K

Other Fundumenentals of American Medical Tec

American Medical Net Income component correlations

About American Medical Financial Statements

Investors use fundamental indicators, such as American Medical's Net Income, to determine how well the company is positioned to perform in the future. Although American Medical's investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
Last ReportedProjected for Next Year
Net Income Applicable To Common Shares223.5 K234.7 K
Net Income174.9 K183.7 K
Net Income From Continuing Ops223.5 K234.7 K
Net Loss(0.10)(0.10)
Net Loss(0.58)(0.55)

Currently Active Assets on Macroaxis

When determining whether American Medical Tec offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of American Medical's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of American Medical Technologies Stock. Outlined below are crucial reports that will aid in making a well-informed decision on American Medical Technologies Stock:
Check out the analysis of American Medical Correlation against competitors.
You can also try the CEOs Directory module to screen CEOs from public companies around the world.
Is there potential for Health Care Equipment & Supplies market expansion? Will American introduce new products? Factors like these will boost the valuation of American Medical. If investors know American will grow in the future, the company's valuation will be higher. Understanding fair value requires weighing current performance against future potential. All the valuation information about American Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.06)
Revenue Per Share
0.243
Quarterly Revenue Growth
(0.19)
Return On Assets
(0.17)
The market value of American Medical Tec is measured differently than its book value, which is the value of American that is recorded on the company's balance sheet. Investors also form their own opinion of American Medical's value that differs from its market value or its book value, called intrinsic value, which is American Medical's true underlying value. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. Because American Medical's market value can be influenced by many factors that don't directly affect American Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Understanding that American Medical's value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether American Medical represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. Meanwhile, American Medical's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.